JPRN-UMIN000024290已完成未知
The study of H.pylori third line eradication therapy using Vonoprazan - The study of H.pylori third line eradication therapy using Vonoprazan
ational Hospital Organization National Kochi Hospital gstroenterology0 个研究点目标入组 10 人开始时间: 2016年10月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnancy or lactation. Past history of allergy for the drugs used in this therapy . Sever liver dysfunction, sever renal dysfunction, sever heart dysfunction. Patients who are disqualified for the sutdy by physicians.
研究者
相似试验
已完成
不适用
Analysis of third-line H. pylori eradication therapy with sitafloxaciPatients with H. pylori eradication failure after first- and second-line therapyJPRN-UMIN000001902Department of Gastroenterology, University of Tokyo50
已完成
不适用
Evaluation of effectiveness of H.pylori eradication on regression of gastric precancerous lesions in the first degree relatives of patients with gastric cancer. A long term double blind randomized controlled clinical trialGastric precancerous lesions.Disease of stomach and duodenum, unspecifiedIRCT138802071852N1Digestive Disease Research Center, Tehran University of Medical Sciences600
已完成
3 期
The efficacy and safety of third line H. pylori eradication therapy with sitafloxacin, amoxicillin and PPIH. pylori-positve patients after the 2nd line eradication failureJPRN-UMIN000013194Keio University School of Medicine100
已完成
3 期
The efficacy and safety of third line H. pylori eradication therapy with sitafloxacin, metronidazole and PPIH. pylori-positve patients after the 2nd line eradication failure or penicillin-allergic patientsJPRN-UMIN000013195Keio University School of Medicine100
已完成
不适用
Third regimen for eradication of Helicobacter pylori resistant against first and sdcond regimeHelicobacter pylori infectionJPRN-UMIN000008375Osaka City University Graduate School of Medicine100